A comparative study on the efficacy of intravenous oxytocin and carbetocin in the prevention and management of postpartum hemorrhage in tertiary care hospital in Uttar Pradesh, India

Background: Postpartum hemorrhage (PPH) remains a leading cause of maternal morbidity and mortality. Oxytocin is widely used as the first-line uterotonic agent; however, carbetocin, a long-acting oxytocin analogue, has shown promise in reducing the need for additional interventions. Aims and Objectives: The aims and objectives of the study are to compare the effectiveness and safety of intravenous oxytocin and intravenous carbetocin in the prevention and management of PPH among pregnant women undergoing lower-segment cesarean section and vaginal delivery. Materials and Methods: This prospective, randomized, comparative study was conducted on 100 women (50 in each group) receiving either intravenous oxytocin or carbetocin immediately after delivery. Baseline maternal characteristics, incidence of PPH, need for additional interventions, and side effects were recorded. The data were entered in MS Excel. Analysis was carried out using Jamovi v2.3.26.0, and P<0.05 was considered statistically significant. Results: Baseline characteristics such as age, body mass index, gravida status, and gestational age were comparable between the two groups (P>0.05). The overall incidence of PPH was 24%, with slightly higher rates in the oxytocin group (54.2%) compared to the carbetocin group (45.8%). The need for additional uterotonics, uterine massage, and blood transfusion was more frequent in the oxytocin group. Surgical interventions, including B-Lynch sutures and hysterectomy, were only required in the oxytocin group. The carbetocin group reported fewer side effects, most notably lower rates of nausea, vomiting, and hypotension. Conclusion: Carbetocin is a safe and effective alternative to oxytocin for the prevention of PPH. It is associated with reduced need for additional interventions and fewer side effects, making it a favorable option in both vaginal and cesarean deliveries.

Authors

Institutions

Publication Details

Journal
Asian Journal of Medical Sciences
Published
2025-09-01
DOI
https://doi.org/10.71152/ajms.v16i9.4715
Primary Topic
Maternal and fetal healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A comparative study on the efficacy of intravenous oxytocin and carbetocin in the prevention and management of postpartum hemorrhage in tertiary care hospital in Uttar Pradesh, India

Anjali Chaudhari, Vandana Vandana, Diwas Gautam, Pradeep Kumar Verma
Asian Journal of Medical Sciences
Maternal and fetal healthcare
article

A comparative study on the efficacy of intravenous oxytocin and carbetocin in the prevention and management of postpartum hemorrhage in tertiary care hospital in Uttar Pradesh, India

Anjali Chaudhari, Vandana Vandana, Diwas Gautam, Pradeep Kumar Verma
article en

Abstract

Background: Postpartum hemorrhage (PPH) remains a leading cause of maternal morbidity and mortality. Oxytocin is widely used as the first-line uterotonic agent; however, carbetocin, a long-acting oxytocin analogue, has shown promise in reducing the need for additional interventions. Aims and Objectives: The aims and objectives of the study are to compare the effectiveness and safety of intravenous oxytocin and intravenous carbetocin in the prevention and management of PPH among pregnant women undergoing lower-segment cesarean section and vaginal delivery. Materials and Methods: This prospective, randomized, comparative study was conducted on 100 women (50 in each group) receiving either intravenous oxytocin or carbetocin immediately after delivery. Baseline maternal characteristics, incidence of PPH, need for additional interventions, and side effects were recorded. The data were entered in MS Excel. Analysis was carried out using Jamovi v2.3.26.0, and P<0.05 was considered statistically significant. Results: Baseline characteristics such as age, body mass index, gravida status, and gestational age were comparable between the two groups (P>0.05). The overall incidence of PPH was 24%, with slightly higher rates in the oxytocin group (54.2%) compared to the carbetocin group (45.8%). The need for additional uterotonics, uterine massage, and blood transfusion was more frequent in the oxytocin group. Surgical interventions, including B-Lynch sutures and hysterectomy, were only required in the oxytocin group. The carbetocin group reported fewer side effects, most notably lower rates of nausea, vomiting, and hypotension. Conclusion: Carbetocin is a safe and effective alternative to oxytocin for the prevention of PPH. It is associated with reduced need for additional interventions and fewer side effects, making it a favorable option in both vaginal and cesarean deliveries.

Asian Journal of Medical SciencesVol. 16(9)
Baba Raghav Das Medical College (IN), Sarojini Naidu Medical College (IN), Autonomous Healthcare (US)
Openalex Percentile: Top 68%
Maternal and fetal healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.